Article info

Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study
Free

Authors

  • Shahab Abtahi Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Centre, Maastricht, The NetherlandsDivision of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The NetherlandsCardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands PubMed articlesGoogle scholar articles
  • Johanna H M Driessen Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Centre, Maastricht, The NetherlandsDivision of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The NetherlandsCardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The NetherlandsNUTRIM School for Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre, Maastricht, The Netherlands PubMed articlesGoogle scholar articles
  • Andrea M Burden Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Centre, Maastricht, The NetherlandsInstitute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH-Zurich, Zurich, Switzerland PubMed articlesGoogle scholar articles
  • Patrick C Souverein Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands PubMed articlesGoogle scholar articles
  • Joop P van den Bergh Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Centre, Maastricht, The NetherlandsFaculty of Medicine and Life Sciences, Hasselt University, Hasselt, BelgiumDepartment of Internal Medicine, VieCuri Medical Centre, Venlo, The Netherlands PubMed articlesGoogle scholar articles
  • Tjeerd P van Staa Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The NetherlandsCentre for Health Informatics, Division of Informatics, Imaging and Data Science, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK PubMed articlesGoogle scholar articles
  • Annelies Boonen Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Centre, Maastricht, The NetherlandsCare and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands PubMed articlesGoogle scholar articles
  • Frank de Vries Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Centre, Maastricht, The NetherlandsDivision of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The NetherlandsCardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The NetherlandsMRC Epidemiology Lifecourse Unit, Southampton General Hospital, Southampton, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Frank de Vries, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, PO BOX 80082, 3508 TB, Utrecht, The Netherlands; f.devries{at}uu.nl
View Full Text

Citation

Abtahi S, Driessen JHM, Burden AM, et al
Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study

Publication history

  • Received July 31, 2020
  • Revised November 12, 2020
  • Accepted November 17, 2020
  • First published December 11, 2020.
Online issue publication 
November 15, 2022

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

  • Lay summary

    Disclaimer : This is a summary of a scientific article written by a medical professional (“the Original Article”). The Summary is written to assist non medically trained readers to understand general points of the Original Article. It is supplied “as is” without any warranty. You should note that the Original Article (and Summary) may not be fully relevant nor accurate as medical science is constantly changing and errors can occur. It is therefore very important that readers not rely on the content in the Summary and consult their medical professionals for all aspects of their health care and only rely on the Summary if directed to do so by their medical professional. Please view our full Website Terms and Conditions.
    Copyright © 2021 BMJ Publishing Group Ltd & European League Against Rheumatism. Medical professionals may print copies for their and their patients and students non commercial use. Other individuals may print a single copy for their personal, non commercial use. For other uses please contact our Rights and Licensing Team.

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.